mounjaro tirzepatide patent expiry us 🚨 Generic Versions of & Zepbound Move Closer as FDA Reviews First Applications The Food and Drug Administration (FDA) is reviewing the first applications for generic versions of Eli Lilly's Generic Mounjaro: Why No FDA

An oral GLP-1 that works on top of existing therapy and without the downsides of insulin could become a foundational treatment in pediatric diabetes management

The case has been referenced in legal discussions as a cautionary example for the legal status of research peptides in 2026

Conclusions and Relevance GLP-1 RA therapy in IIH is associated with significant reductions in medication use, symptoms/signs, and procedural interventions, suggesting its potential as a management strategy

It is particularly effective in assisting patients with long-term weight management

This process preserves the full molecular spectrum of saffron, including volatile compounds like safranal, which are often lost during conventional extraction methods